Regeneron Pharmaceuticals (REGN): Strong On High Volume & Earnings Expectations


Regeneron Pharmaceuticals Inc (NASDAQ: REGN)

Regeneron Pharmaceuticals is having a strong day in the market today after announcing when their next earnings report will be released. This continues a bullish trend that we’ve seen on the stock since October 6th. Today, we’ll talk about when earnings are expected and what analyst expectations are, the volume we’re seeing on REGN today, and what we can expect to see from the stock moving forward. So, let’s get right to it…

REGN Earnings To Come Soon

Regeneron Pharmaceuticals announced today that it will be releasing its earnings results on Wednesday, November 4, 2015. The release will happen before the opening bell and the company will be hosting a conference call and webcast at 8:30 am EST. If you’d like to be part of the conference call, all you need to do is dial (888) 660-6127 for US investors or (973) 890-8355 for international investors. As far as the webcast goes, it will be available on the “Events and Presentations” page at or simply click here to be directed to the page. The presentation will be recorded and available on the Regeneron website for a period of 30 days.

When it comes to earnings, consensus estimates are that REGN will produce $2.62 per share. However, it is important to note that the company does have a great track record with regard to beating consensus estimates on earnings. In fact, through five of the past seven consecutive quarters, REGN has beat wall street expectations with regard to earnings.

REGN Trades On High Volume

As a result of the bullish run we’ve seen lately and investor excitement with regard to the coming earnings release, REGN is currently trading on high volume. According to NASDAQ, REGN trades with an average daily volume of 929,654 shares. However, today, just 39 minutes into the trading session, 322,426 shares have already traded hands. It is clear that investors are excited about Regeneron Pharmaceuticals.

What We Can Expect To See Moving Forward

Moving forward, I’m expecting to see overwhelmingly positive news from Regeneron Pharmaceuticals. The company has proven time and time again that they are capable of producing earnings well above the expectations of Wall Street. With the next earnings report just around the quarter, investor excitement surrounding REGN is likely to continue. So, we should expect to see more gains moving forward.

What Do You Think?

Where do you think REGN is headed and why? Let us know in the comments below!

[Image Courtesy of Live Trading News]


Please enter your comment!
Please enter your name here